logo
Chinese researchers test neural implant that lets amputee to move cursor with mind

Chinese researchers test neural implant that lets amputee to move cursor with mind

Yahoo11 hours ago
China's state-owned broadcaster CCTV reported on Saturday that the country has become second only in the world to start human trials of its advanced invasive brain-computer interface (BCI) technology.
The trial involves a 37-year-old man who lost all four limbs in a high-voltage electrical accident over ten years ago. In March, researchers implanted a coin-sized device and electrodes into his brain. Within weeks, the subject was able to control a cursor on a screen, allowing him to play chess, use a computer, and even game with near-normal skill, according to the CCTV report.
Starting this year, the team will launch small-scale trials involving patients with paralysis or ALS, with plans to expand to as many as 40 participants by 2026. The effort is being led by the Chinese Academy of Sciences' (CAS) Centre for Excellence in Brain Science and Intelligence Technology, alongside Huashan Hospital at Fudan University in Shanghai and several industry partners, the South China Morning Post detailed.
The deep brain stimulation electrode implanted in the patient is the smallest and most flexible of its kind in the world, Chinese media added. Created by the CAS research center, the electrode measures roughly 1/100th the width of a human hair and about one-fifth the thickness of Neuralink's electrodes, explained Zhao Zhengtao, a professor at the academy.
Zhao also noted in a statement released by the CAS that the electrode's exceptional flexibility enables it to bend with the subtle movements of neurons sliding past one another. The design caused minimal disruption to surrounding tissue, with the patient's neurons barely affected by the implantation. Each electrode tip contains 32 sensors that capture brain signals, enabling long-term coexistence with brain tissue without triggering immune rejection.
Before reaching human trials, the technology underwent extensive testing on mice and macaques to evaluate its safety, flexibility, and effectiveness. The implant measures 26mm (1 inch) in diameter and is 6mm thick. The implantation procedure took less than 30 minutes to complete. Surgeons thinned a coin-sized section of the skull above the motor cortex, creating a 5mm opening to insert the electrode.
Before the operation, the surgical team used advanced scans to create a detailed 3D map of the patient's brain, allowing for precise planning. During the surgery, real-time navigation technology guided the team to place the electrode with millimeter-level accuracy, ensuring optimal positioning.
In the coming months, the team will work closely with the patient to train him in controlling robotic arms, enabling him to perform practical tasks such as grasping and manipulating objects in everyday life.
Future phases of the trial may involve more advanced tasks, such as steering complex devices like robotic dogs and embodied AI agents. Beyond its current use, the report emphasized that this technology holds promise for a range of medical applications and offers new treatment options for debilitating neurological disorders such as stroke, ALS, and Alzheimer's disease.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Live Q&A: How Xiaomi Succeeded in EVs Where Apple Failed
Live Q&A: How Xiaomi Succeeded in EVs Where Apple Failed

Bloomberg

timean hour ago

  • Bloomberg

Live Q&A: How Xiaomi Succeeded in EVs Where Apple Failed

Linda Lew Xiaomi has emerged as the only major tech company to successfully break into the EV market — achieving in three years what Apple couldn't in over a decade. Lei Jun's confident jab at Apple during the Beijing SUV launch — paired with nearly 300,000 orders in under an hour — has sparked a global conversation. With its affordable pricing, slick Porsche-like designs, and seamless smartphone integration, Xiaomi's cars are seeking to redefine the smart vehicle landscape. Bloomberg's Annabelle Droulers, Linda Lew, Katrina Nicholas, and Vlad Savov unpack the rapid rise of Xiaomi's EV ambitions, its competitive edge in China's hyper-charged auto market, and what this means for global players like Tesla. Join the Live Q&A on July 7, 2025 at 11 a.m. HKT / 8:30 a.m. IST / 11 p.m. ET (July 6, 2025) Bloomberg digital subscribers and Terminal clients have the exclusive opportunity to ask our team live questions. This conversation will be recorded and be made available to listen and share.

India plans $230 million drone incentive after Pakistan conflict, sources say
India plans $230 million drone incentive after Pakistan conflict, sources say

Yahoo

timean hour ago

  • Yahoo

India plans $230 million drone incentive after Pakistan conflict, sources say

By Sarita Chaganti Singh and Shivam Patel NEW DELHI (Reuters) -India will launch a $234 million incentive programme for civil and military drone makers to reduce their reliance on imported components and counter rival Pakistan's programme built on support from China and Turkey, three sources told Reuters. India's push to build more home-grown drones stems from its assessment of the four-day clash with Pakistan in May that marked the first time New Delhi and Islamabad utilized unmanned aerial vehicles at scale against each other. The nuclear-armed neighbours are now locked in a drones arms race. New Delhi will launch a 20 billion Indian rupees ($234 million) programme for three years that will cover manufacture of drones, components, software, counter drone systems, and services, two government and one industry source, who did not want to be named, told Reuters. Details of the programme have not been previously reported and its planned expenditure is higher than the modest 1.2 billion rupees production-linked incentive scheme New Delhi launched in 2021 to promote drone start-ups, which have struggled to raise capital and invest in research. India's civil aviation ministry, which is leading the incentives programme, and defence ministry did not immediately respond to e-mails seeking comment. Reuters previously reported that India plans to invest heavily in local industry and could spend as much as $470 million on unmanned aerial vehicles over the next 12 to 24 months, in what government and military officers said would be a staggered approach. In the past, India has mainly imported military drones from its third-largest arms supplier, Israel, but in recent years its nascent drone industry has scaled up its cost-effective offerings, including for the military, although reliance on China continues for certain components such as motors, sensors and imaging systems. Through the incentives, India is aiming to have at least 40% of key drone components made in the country by the end of fiscal year 2028 (April-March), the two government sources said. "During (the India-Pakistan) conflict there was quite a lot of use of drones, loitering munitions and kamikaze drones on both sides," Indian Defence Secretary Rajesh Kumar Singh said last week. "The lesson that we've learned is that we need to double down on our indigenisation efforts to ensure that we build a large, effective, military drone manufacturing ecosystem." India bans import of drones but not their components and the government has planned additional incentives for manufacturers that procure parts from within the country, the two government sources said. The state-run Small Industries Development Bank of India would also support the incentive programme by providing cheap loans for working capital, research and development needs for the firms, the government sources added. Currently, there are more than 600 drone manufacturing and associated companies in India, according to estimates shared by an industry source involved in the discussions for the incentives programme. ($1 = 85.5950 Indian rupees) Sign in to access your portfolio

Lunit partners with Microsoft to develop AI cancer diagnostic tools
Lunit partners with Microsoft to develop AI cancer diagnostic tools

Yahoo

time2 hours ago

  • Yahoo

Lunit partners with Microsoft to develop AI cancer diagnostic tools

South Korean AI company Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice. According to Lunit, the partnership aligns with its vision to create AI tools that fit smoothly into everyday clinical care. The collaboration will involve Lunit and Microsoft's development of a tool for customising AI models that will be embedded into Microsoft's Azure cloud platform, thereby allowing Lunit users to customise their AI models using site-specific clinical data. Lunit adds that the approach will mitigate cross-site model performance variability, which it views as a key hurdle in the deployment of AI diagnostics in real-world clinical settings. The developer also plans to use Microsoft's agentic AI frameworks, which are designed to support intelligent task automation, to develop workflow automation tools. According to Lunit, these solutions will simplify clinical decision-making and improve operational efficiency for its AI cancer diagnostic tools. Lunit's AI tools include the SCOPE HER2 algorithm for human epidermal growth factor receptor 2 (HER2) biomarker evaluation in metastatic colorectal cancer (mCRC) patients undergoing HER2-targeted therapy, and INSIGHT DBT for identifying breast cancer in mammogram images. Lunit CEO Brandon Suh commented: 'Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the US and beyond.' According to GlobalData analysis, the use of AI across healthcare is rapidly advancing, with the market projected to reach a valuation of around $19bn by 2027. Radiology has emerged as one of the most common areas in which AI is being applied – chiefly as a means to drive efficiencies and glean insights that humans evaluating radiologic images could miss. Naveen Valluri, general manager of health and life sciences data and AI at Microsoft, commented: 'With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations. 'By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we're accelerating the development of integrated solutions for radiology and beyond.' "Lunit partners with Microsoft to develop AI cancer diagnostic tools" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store